# To Evaluate Safety and Efficacy of CGBIO Stent Compared to Biomatrix Flex Stent

Study · id `cardio:ct-nct03089450` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03089450](<https://clinicaltrials.gov/study/NCT03089450>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03089450

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Acute care and long-term living  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 112 participants.

## Technical summary

Registry record NCT03089450. Randomized; single masking; primary purpose treatment. Start 2017-03-22 (actual); primary completion 2017-09 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 112 participants (planned count; ClinicalTrials.gov record NCT03089450, source copy `cardio:ctgov-nct03089450-2017-03-28`, retrieved 2026-10-26)
- Started: 2017-03-22 (actual) (ClinicalTrials.gov record NCT03089450, source copy `cardio:ctgov-nct03089450-2017-03-28`, retrieved 2026-10-26)
- Primary completion: 2017-09 (anticipated) (ClinicalTrials.gov record NCT03089450, source copy `cardio:ctgov-nct03089450-2017-03-28`, retrieved 2026-10-26)
- Completion: 2018-06 (anticipated) (ClinicalTrials.gov record NCT03089450, source copy `cardio:ctgov-nct03089450-2017-03-28`, retrieved 2026-10-26)
- Countries: South Korea (ClinicalTrials.gov record NCT03089450, source copy `cardio:ctgov-nct03089450-2017-03-28`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03089450-2017-03-28`, retrieved 2026-10-26)

## The registry's words

- Brief title: To Evaluate Safety and Efficacy of CGBIO Stent Compared to Biomatrix Flex Stent
- Condition: Ischemic Heart Disease
- Condition: Stable Coronary Artery Disease
- Condition: Stable Angina
- Condition: Unstable Angina
- Condition: NSTEMI - Non-ST Segment Elevation MI
- Intervention (Device): CGBio stent
- Intervention (Device): Biomatrix flex
- Lead sponsor: CGBio Inc.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry condition terms include this condition: Non-ST-elevation heart attack (NSTEMI) (`cardio:nstemi`)
- Registry condition terms include this condition: Stable angina (`cardio:stable-angina`)
- Registry condition terms include this condition: Unstable angina (`cardio:unstable-angina`)

## Provenance

Content hash: 5085b5bc6704df8643740ed7173b3f68cc00a1776d6078fd31b778448d3acea7
Last substantive edit: 2026-10-31
Evidence last checked: Not recorded
